Novartis, Teva aid Russian police investigation

In an investigation of local drug distributors, Russian police visited Novartis and Teva facilities. The companies are suspected of no wrongdoing. The investigation targets a carve-up by distributors of the market for supplying the state healthcare system with essential drugs, says Reuters.

The government runs a system of subsidized purchases of drugs for low-income citizens. An investigation into the system showed the bulk of state supply contracts, worth more than $2 billion, went to six distribution firms between 2006 and 2008.

Both of the drugmakers are investing hundreds of millions of dollars in the Russian market.

- here's the story
- here's more

Suggested Articles

South Korea’s Celltrion, which has a massive biologics site in Songdo, has decided it is time to build some operations in China.

WuXi Biologics is taking control of a Bayer plant in Germany and agreed it could serve as a backup facility for supply of hemophilia drug Kovaltry.

A Chinese OTC drugmaker gets the distinction of ringing in the new year as the first company to be slapped with an FDA warning letter.